According to the new market research report “Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal) and Region – Global Forecast to 2022″, published by MarketsandMarkets™, The chromatography resin market is projected to grow from USD 1.72 billion in 2016 to USD 2.46 billion by 2021, at a CAGR of 7.41% from 2016 to 2021. The demand for chromatography resins is increasing due to their increasing usage in therapeutic applications.
Chromatography Resin Market: Browse 94 Market Data Tables and 41 Figures spread through 145 Pages
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=933
Some of the major players operating in this market include GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Tosoh Corporation (Japan), Purolite Corporation (U.S.), Repligen Corporation (U.S.), Mitsubishi Chemical Corporation (Japan), and Avantor Performance Materials Inc. (U.S.). These players have adopted various strategies to expand their global presence and increase their market shares.
The growth of the chromatography resin market was largely influenced by new product launches and expansions during the past five years. New product launches and expansions, contracts & agreements, and acquisitions are some of the strategies adopted by these players to achieve growth in the market. Companies such as GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Tosoh Corporation (Japan) adopted strategies such as new product launches and expansions to strengthen their market position and widen their product portfolio.
GE Healthcare, the leading chromatography resin company, adopted various strategies such as contracts & new product launches, and investments to widen its product portfolio. For instance, in June 2016, GE Healthcare launched Capto Q XP, a strong anion exchange chromatography resin. The company also invested USD 100 million in 2015 in a manufacturing facility in Uppsala, Sweden. This strategy will enable the company to increase its chromatography resin manufacturing capacity.
Read More Context at: https://www.marketsandmarkets.com/PressReleases/chromatography-resins.asp
Tosoh Corporation has undertaken several new product launches to provide chromatography resins for different chromatography techniques to its customers. For instance, Tosoh Corporation launched TOYOPEARL Sulfate-650F in 2016, a strong cation exchange resin that exhibits high salt tolerance. This resin is available for sale in the Americas from Tosoh Bioscience LLC. Tosoh Corporation is focused on expanding and improving its chromatography business segment through the development of innovative products and technologies. The company has a significant presence in Asia-Pacific and is now focused on increasing its market share in Europe and North America.